December 23, 2025

Pleio CEO Michael Oleksiw examines why, despite decades of digital innovation and billions invested, medication adherence remains stuck at 50%. Drawing on analysis of more than 140,000 patient conversations, he explores how the “Underminers” shape patient behavior and why the future of pharma depends on combining AI-driven insight with human connection to create lasting adherence.

December 3, 2025

Pleio’s AI platform, OLLIE, analyzed over 140,000 patient interactions to identify the top drivers of non-adherence across seven dimensions, including emotion, knowledge, and skills.

November 13, 2025

On “The Tech Glow Up” live from HLTH 2025, Vital.io and Pleio share how AI can make healthcare more human—from translating medical jargon to uncovering emotional barriers that hinder adherence and patient trust.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |   SUPPLIER CONDUCT   |  CAREERS



© 2025 Pleio, Inc All rights reserved.